Роль бисопролола в ведении пациентов с артериальной гипертензией
Аннотация
Об авторе
С. В. НедогодаРоссия
Список литературы
1. Alderman M.H, Cohen H, Madhavan S. Diabetes and cardiovascular events in hypertensive patients. Hypertension 1999; 33: 1130-4.
2. Bradley H.A, Wiysonge C.S, Volmink J.A et al. How strong is the evidence for use of beta - blockers as first - line therapy for hypertension? Systematic review and meta - analysi. J Hypertension 2006; 24: 2131-41.
3. Elliott W.J, Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta - analysis. Lancet. 2007; 369: 201-7.
4. Lindholm L.H, Carlberg B, Samuelsson O. Shoud β-blockers first chouse in the treatment of primary hypertension? A meta - analisys. Lancet 2005; 366: 1545-53.
5. Mancia G, Grassi G, Zanchetti A. New - onset diabetes and antihypertensive drugs. J Hypertens 2006; 24: 3-10.
6. Julius S et al. Usefulness of heart rate to predict cardiac events in treated patients with high - risk systemic hypertension. Am J Cardiol 2012; 109 (5): 685-92.
7. Poulter N.R, Dobson J.E, Sever P.S et al. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo - Scandinavian Cardiac Outcomes Trial). J Am Coll Cardiol 2009; 54: 1154-61.
8. Okin P.M et al. All - cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy. Eur Heart J 2010; 31: 2271-9.
9. Mengden T, Vettr W. The efficacy of bisoprolol in the treatment of hypertension. Rev Contemp Pharmacother 1997; 8: 55-67.
10. Amabile G, Serradimigni A. Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double - blind tria. Eur Heart J 1987; 8 (Suppl. M): 65-9.
11. Haasis R, Bethge H. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of trearment with bisoprolol and metoprolol: a randomized multicentre double - blind study (BISOMET). Eur Heart J 1987; 8: 103-13.
12. Buhtel F.R, Berglund G, Anderson O.K et al. Smoking status and cardioselective beta - blocade antihypertensive therapy: the Bisoprolol International Multicentre Study (BIMS). J Hypertens 1986; 4: 144-6.
13. Подзолков В.И., Осадчий К.К. Рациональный выбор бета - адреноблокатора для лечения артериальной гипертензии: фокус на Бисогамму. РМЖ. 2008; 16 (16): 4-8.
14. Teresa E, Gonzdlez M, Camacho-Vazquez C, Tabuenca M. Effect of bisoprolol on left ventricular hypertrophy in essential hypertension. Cardiovasc Drugsther 1994; 8: 837-43.
15. Broekman C.P, Haensel S.M, Van de Ven L.L, Slob A.K. Bisoprolol and hypertension: effects on sexual functioning in men. J Sex Marital Ther 1992; 29: 325-31.
16. Prisant L.M, Weir M.R, Frishman W.H et al. Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide. J Clin Hypertens (Greenwich) 1999; 1 (1): 22-6.
17. Леонова М.В. Бета - блокаторы и органопротекция при артериальной гипертонии. Клин. фармакология и терапия. 2012; 21 (3): 26-30.
18. Brode O-E. The pharmacology of bisoprolol. Rev Contemp Pharmacother 1997; 8: 21-33.
19. Остроумова О.Д., Максимов М.Л. Возможности применения высокоселективных бета - адреноблокаторов у больных с сопутствующими заболеваниями//Consilium Medicum. 2012; 14 (1): 721-5.
20. Janka H.U et al. Influence of bisoprolol on blood glucose, glucosuria and haemoglobin AL in non - insulindependent diabetics. J Cardiovasc Pharmacol 1986; 8 (Suppl. 11): 96.
21. The Task Force on Beta-Blockers of the European Society of Cardiology. Expert consensus document on β-adrenergic receptor blockers. Eur Heart J 2004; 25: 1341-62.
22. Frishman W.H, Burris Jf, Mroczek W.J et al. First - line therapy with low - dose Bisoprolol fumarate and lowe - dose Hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35: 182-8.
23. Семенов А.В., Кукес В.Г. Клинико - фармакологические аспекты применения бисопролола. РМЖ. 2007; 15 (15): 38-43.
Рецензия
Для цитирования:
Недогода С.В. Роль бисопролола в ведении пациентов с артериальной гипертензией. Системные гипертензии. 2016;13(3):32-34.
For citation:
Nedogoda S.V. The role of bisoprolol in the management of patients with arterial hypertension. Systemic Hypertension. 2016;13(3):32-34.
Послать статью по эл. почте 